Srs Capital Advisors, Inc. Horizon Therapeutics Public LTD CO Transaction History

Srs Capital Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $2,969 - $3,472	30 Added 50.85%	89 $10,000
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $1,348 - $1,573	14 Added 31.11%	59 $6,000
Q1 2023 May 16, 2023	SELL	$107.32 - $113.5 $214 - $227	-2 Reduced 4.26%	45 $4,000
Q4 2022 Feb 24, 2023	BUY	$62.39 - $113.8 $1,934 - $3,527	31 Added 193.75%	47 $5,000
Q3 2022 Nov 03, 2022	SELL	$58.92 - $84.67 $530 - $762	-9 Reduced 36.0%	16 $1,000

Q2 2022 Aug 22, 2022	SELL	$79.4 - $116.36 $1,667 - $2,443	-21 Reduced 45.65%	25 $2,000
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $3,370 - $4,282	39 Added 557.14%	46 $5,000
Q3 2021 Nov 05, 2021	BUY	$91.91 - $110.37 $643 - $772	7 New	7 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.